In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Podcast: Thermo Fisher’s Meron Mathias On Why Environmental Sustainability Must Be A Top Priority

Company Drives For Sustainability Compliance 'In The Right Way'

Executive Summary

Meron Mathias is vice president of CSR and sustainability at Thermo Fisher, whose specialty diagnostics division makes it the fifth leading player by revenues in the global IVD industry. In this podcast, she reflects on Thermo Fisher’s early commitment to ESG and sustainability reporting, its Scope 1, 2 and 3 targets and how regulation is moving industry towards a mandatory disclosure landscape.

Thermo Fisher Scientific was one of the first companies in its peer group to have its near and long-term net-zero targets validated by the Science Based Targets initiative (SBTi). The company aims to achieve net zero by 2050, and has set a series of interim milestones, including a recently added global energy target based on renewable electricity.

In this podcast, Meron Mathias explains Thermo Fisher’s sustainability targets within the E in ESG. She conveys the importance of concurrent diversity, equity and inclusivity (DEI) compliance, to help ensure all elements of the sustainability agenda progress at the required pace. She takes forward the position she laid out in a 2023 interview with In Vivo. (Also see "The E in ESG: Thermo Fisher On Why The ‘How’ Is More Important Than The ‘When’" - In Vivo, 22 May, 2023.)

Since joining the company as head of CSR and sustainability in 2020, and then being elevated two years later to vice president, Meron has focused on enabling Thermo Fisher’s customers to make the world healthier, cleaner and safer through a combination of innovative technologies and ethical business processes.

She explains the important elements in compliance, what guides Thermo Fisher’s policy on compliant innovation and R&D, and the “five environmental impact areas” it factors into the innovation process to help ensure: reduced presence of hazardous chemicals, reduced waste generation, enhanced energy efficiency, use of responsible packaging practices and promotion of product longevity.

 

 

Meron highlights that innovating “in the right ways to support environmental sustainability” provides a competitive advantage. She stresses: “Our Greener by design program has shown that that greener approaches can often lower costs for both the company and our customers.”

But because business aims and sustainability must go hand in hand, Thermo Fisher has established a framework to help ensure its supply chain mirrors its own sustainability efforts and achievements.

And operationally, Thermo Fisher employees play a key role in the company’s community engagement. Its practical process improvement (PPI) program empowers all colleagues to drive efficiency, and an internal generative AI platform enables staff to leverage the benefits of AI to improve productivity.

Meron says: “We take an approach that's really looking at operations, partnerships and innovation to drive progress. There will continue to be opportunities to adapt our approach as new innovations come onto the market. We all have to remain agile and look for those levers to accelerate our progress.”

Podcast Themes And Timestamps:

1.38        Sustainability compliance “in the right way” – Thermo Fisher’s priorities

3.57        Thermo Fisher’s sustainability timelines and targets

5.53        ESG guiding strategies and “going the extra mile”   

10.43      How business planning is influenced by the environmental agenda at Thermo Fisher

13.02     ESG compliance cuts across all the whole company. More complex regulations are coming into force

14.25     Innovating “in the right way” – the adoption of green approaches while reconciling business needs with a responsible market stance

15.30     Bringing the whole value chain on board at the same time: the primacy of partnerships, investing in training and the role of innovation

18.29     Supply chain partners who have set, or committed to, science-based targets; progress towards Thermo Fisher’s sign-up target of 90% of suppliers by spend

19.54     Diversity – the S in ESG – and the need to make concurrent progress alongside the environmental agenda   

21.36     Innovation and R&D – new approaches to deliver competitive edge

22.59     “Find a better way every day”: Thermo Fisher’s “five impact areas” on the innovation journey

25.06     Colleagues’ roles in ESG, including the PPI concept at Thermo Fisher

26.37     Thermo Fisher has come far in ESG: how far has it yet to go?     

27.49     Final ESG comments, completing a resource that others can refer to

29.47     Thank you, Meron

 





Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

IV154711

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel